Methotrexate (MTX) is an effective drug used to treat various diseases, especially rheumatological diseases. However, myelosuppression is a severe side effect, the frequency of which increases in patients with renal insufficiency. Here, we presented a chronic hemodialysis patient who developed pancytopenia and mucositis after using low-dose MTX to treat psoriasis.
Birincil Dil | İngilizce |
---|---|
Konular | İç Hastalıkları |
Bölüm | Case Reports |
Yazarlar | |
Yayımlanma Tarihi | 1 Nisan 2022 |
Gönderilme Tarihi | 15 Şubat 2022 |
Kabul Tarihi | 9 Mart 2022 |
Yayımlandığı Sayı | Yıl 2022 Cilt: 4 - Supplement 1 |